caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871859728

Andrew LaccettiM.D.

Hematology-OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
80.4
Quality
71.5
Cost
70.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.23%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
378
Unique beneficiaries
—
Total services
957
Distinct HCPCS
4
Medicare payment
$86K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — above median (cohort median 883).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$10K
Payment records
17
By payment type
Consulting Fee$5K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3K
Travel and Lodging$2K
Food and Beverage$346
PRESCRIBING · PART D · 2024
Total Rx claims
1,624
Beneficiaries
—
Total drug cost
$4.4M
Distinct drugs
15
Brand share
30.4%
Top prescribed drugs
Prednisone488 claims
Abiraterone Acetate428 claims
Relugolix154 claims
Tamsulosin Hcl124 claims
Enzalutamide119 claims